Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin Consolidation vs Rituximab Maintenance in Follicular Lymphoma
NCT00662948Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Dec 2008
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in follicular lymphoma (FL), sponsored by Fundación PETHEMA. Started Dec 2008; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00662948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662948.